MIR3179-3

Across TCGA pan-cancer cohorts, MIR3179-3 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated MIR3179-3 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR3179-3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3179-3 expression acts as an unfavorable survival marker.

STAD, LGG, and PAAD are the cancer types where MIR3179-3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	II,III,IV	0.215	0.676	.011	72	view →
LGG	OS	Tertile	All	0.250	0.830	.001	36	view →
PAAD	OS	Tertile	All	0.197	0.613	.016	27	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

MIR3179-3–STAD (OS)

Open the STAD breakdown →